Cerebrotendinous XanthomatosisSymptoms, Doctors, Treatments, Advances & More
Cerebrotendinous Xanthomatosis Overview
Learn About Cerebrotendinous Xanthomatosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Aad Verrips practices practicing medicine in Nijmegen, Netherlands. Verrips is rated as an Elite expert by MediFind in the treatment of Cerebrotendinous Xanthomatosis. They are also highly rated in 2 other conditions, according to our data. Their clinical expertise encompasses Xanthoma, Cerebrotendinous Xanthomatosis, KBG Syndrome, and Aicardi Syndrome.
Ron Wevers practices practicing medicine in Nijmegen, Netherlands. Mr. Wevers is rated as an Elite expert by MediFind in the treatment of Cerebrotendinous Xanthomatosis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Xanthoma, Cerebrotendinous Xanthomatosis, Cutis Laxa, and Delta-1-Pyrroline-5-Carboxylate Dehydrogenase Deficiency.
Suburban Geriatrics Inc
Robert Pearlstein is a primary care provider, practicing in Geriatrics and Internal Medicine in Plymouth Meeting, Pennsylvania. Dr. Pearlstein is rated as an Advanced provider by MediFind in the treatment of Cerebrotendinous Xanthomatosis. He is also highly rated in 180 other conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Painful Swallowing, Gastrostomy, and Endoscopy. Dr. Pearlstein is board certified in .
Summary: The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepo...
Summary: General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.